Hydralazine tablets bulk supplier for pharma manufacturers

Hydralazine Tablets 10 mg, 25 mg, 50 mg, 100 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg, 25 mg, 50 mg, 100 mg

Reference Brands: Apresoline(US & Eu)

Hydralazine is a direct vasodilator that relaxes arteriolar smooth muscle, reducing blood pressure and afterload. It effectively treats hypertension and heart failure. Benefits include rapid blood pressure lowering, symptom relief, improved cardiac output, decreased stroke risk, and better long-term cardiovascular health, especially in hypertensive emergencies.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Hydralazine tablets, marketed as Apresoline, are approved in the US by the FDA and in the EU via EMA for managing severe hypertension and heart failure. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Adequate regional adherence supports timely approval, safe medication use, and worldwide availability, helping healthcare providers manage cardiovascular risks effectively across regions.

Hydralazine Tablets — third party manufacturing & bulk supply

Hydralazine Tablets 10 mg, 25 mg, 50 mg, 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Hydralazine Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Hydralazine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Hydralazine Tablets →

Back to Listing

Frequently Asked Questions

Hydralazine tablets is listed as Tablets in 10 mg, 25 mg, 50 mg, 100 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Hydralazine tablets is referenced against Apresoline(US & Eu). Reference brands are shown for identification only and remain the property of their respective trademark owners.